Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Oct 5;13:16743. doi: 10.1038/s41598-023-42331-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Five biomarkers predict prevalent AF. Higher levels of ANGPT2, BMP10, FGF23, IGFBP7, and NTproBNP are consistently associated with increased odds of prevalent AF as suggested by univariate OR and 95% CI of quantified biomarkers for the discovery and validation cohorts. Biomarker levels have been adjusted for age, sex, BMI, eGFR, heart failure, stroke/TIA, and hypertension status. BMI body mass index, eGFR estimated glomerular filtration rate, TIA transient ischemic attack, ANGPT2 angiopoietin 2, BMI body mass index, BMP10 bone morphogenetic protein 10, CRP high-sensitivity C-reactive protein, CA125 cancer antigen 125, CI confidence intervals, eGFR estimated glomerular filtration rate, ESM1 endothelial cell specific molecule 1, FGF23 fibroblast growth factor 23, FABP3 fatty acid binding protein 3, GDF15 growth differentiation factor 15, IGFBP7 insulin like growth factor binding protein 7, IL6 interleukin 6, NTproBNP N-terminal pro-B-type natriuretic peptide, OR odds ratio, TnT high-sensitivity cardiac troponin T.